Gilead Wins Historic Approval for Twice-Yearly HIV Drug
The FDA accepted Gilead’s landmark long-acting HIV remedy lenacapavir Wednesday afternoon. The drug shall be marketed underneath the identify Yeztugo.Lenacapavir...
Pharmaceutical Updates
Bavarian Nordic nets $160m from precedence assessment voucher sale
Precedence assessment vouchers are sometimes purchased by corporations seeking to dramatically scale back FDA assessment time for a brand new...
Pharmalittle: We’re studying a few new FDA evaluate program, proposed DTC advert modifications, and extra
Hey, everybody, and the way are you at this time? We're doing simply effective, thanks, particularly because the center of...
FDA Rolls Out Commissioner’s Precedence Voucher Program to Pace Drug Evaluations
The FDA launched a brand new precedence overview voucher program on Tuesday that it says may shorten the timeline for...
Supernus makes melancholy drug play with $795m Sage buyout
Share worth in Sage surged 26% at market open within the US following the announcement on 16 June. Credit score:...
STAT+: HHS tries pushing pharma to the negotiating desk
Need to keep on prime of the science and politics driving biotech right now? Enroll to get our biotech publication in your...
AstraZeneca Makes $5.3B AI Guess With China’s CSPC for Power Illness Drugs
AstraZeneca put down $110 million upfront to companion with China’s CSPC Pharmaceutical, aiming to leverage AI to develop novel oral...
AstraZeneca faucets Chinese language biotech in $5.2bn persistent illness analysis deal
AstraZeneca and CSPC will uncover and develop pre-clinical candidates for a number of targets. Credit score: Lutsenko_Oleksandr by way of...
RFK Jr.’s new CDC vaccine panel sparks debate on conflicts
WASHINGTON — When well being secretary Robert F. Kennedy Jr. dismissed the 17 members of the important thing panel that advises...
Moderna Wins Expanded Label for mRNA RSV Shot as New ACIP Members Query mRNA Know-how
The FDA signed off on the broader use of Moderna’s mRNA vaccine for respiratory syncytial virus in a ruling introduced...
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
Shares in BioNTech rose 0.17% at market open on 12 July, reaching a value of $105.64, following the announcement. Credit...
A better take a look at the brand new members of the CDC vaccine advisory panel
For greater than a half-century, the Facilities for Illness Management and Prevention has relied on outdoors consultants to information the...
Genentech Lays Off 143 Staff in South San Francisco Reshuffle
After enduring a number of rounds of layoffs final yr, Genentech’s staff are dealing with extra uncertainty because the Roche...
Mosanna Therapeutics secures $80m in funding
The funds might be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit score: Pixel-Shot/Shutterstock. Mosanna Therapeutics has...
Merck, Keros, Metsera, Axsome newest
Need to keep on prime of the science and politics driving biotech right this moment? Join to get our biotech publication in...
